benzylamine has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biron, S; Carpéné, C; Galitzky, J; Hasnaoui, M; Joanisse, DR; Les, F; Marceau, P; Mauriège, P; Richard, D | 1 |
| Attané, C; Balogh, B; Brenachot, X; Carpéné, C; Dunkel, P; Földi, A; Iffiú-Soltesz, Z; Mátyus, P; Mercader, J; Valet, P | 1 |
2 other study(ies) available for benzylamine and Metabolic Diseases
| Article | Year |
|---|---|
Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.
Topics: Adipose Tissue, White; Adult; Amine Oxidase (Copper-Containing); Benzylamines; Female; Humans; Hydrogen Peroxide; Kinetics; Metabolic Diseases; Middle Aged; Obesity, Morbid; Organ Specificity | 2016 |
SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
Topics: 3T3 Cells; Adipocytes; Adipokines; Amine Oxidase (Copper-Containing); Animals; Apelin; Benzylamines; Gene Expression Regulation; Glucose; Humans; Hydrogen Peroxide; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metabolic Diseases; Mice; Semicarbazides | 2010 |